首页 | 本学科首页   官方微博 | 高级检索  
     

吗替麦考酚酯治疗难治性原发性肾病综合征疗效观察
引用本文:汤京华,汤婷,方莉,冯曦. 吗替麦考酚酯治疗难治性原发性肾病综合征疗效观察[J]. 中国药师, 2011, 14(1): 104-105
作者姓名:汤京华  汤婷  方莉  冯曦
作者单位:南京医科大学附属常州第二人民医院肾内科,江苏常州,213003
摘    要:目的:观察吗替麦考酚酯(MMF)治疗难治性原发性肾病综合征的疗效及安全性。方法:22例原发性难治性肾病综合征患者,予以MMF治疗,初始剂量1.5-2.0g·d^-1,3-6个月后逐渐减量,疗程6个月;同时口服泼尼松片30—60mg·d^-1。治疗前及治疗后3、6个月测定患者的24h尿蛋白定量、血清白蛋白、血常规、尿常规、肝肾功能,观察记录不良反应。结果:经治疗患者尿蛋白定量下降,血清白蛋白水平上升(P〈0.01);治疗前后肾功能无明显变化;不良反应可以耐受。结论:MMF治疗难治性原发性肾病综合征有效、安全,值得临床推广使用。

关 键 词:吗替麦考酚酯  难治性肾病综合征  泼尼松

Effect of Mycophenolate Mofetil in Treatement of Refractory Nephropathy Syndrome
Tang Jinghua,Tang Ting,Fang Li,Feng Xi. Effect of Mycophenolate Mofetil in Treatement of Refractory Nephropathy Syndrome[J]. China Pharmacist, 2011, 14(1): 104-105
Authors:Tang Jinghua  Tang Ting  Fang Li  Feng Xi
Affiliation:Tang Jinghua,Tang Ting,Fang Li,Feng Xi(Department of Nephrology,Second Hospital of Changzhou Affiliated to Nanjing Medical University,Jiangsu Changzhou 213003,China)
Abstract:Objective:To observe the efficacy and safety of mycophenolate Mofetil(MMF) in treatment of refractory nephropathy syndrome.Method:Twenty-two patients with refractory nephropathy syndrome were treated by MMF.The clinical data was observed in the 12th week and 24th week.Result:The proteinuria of the patients decreased while serum albumin increased significantly(P<0.01) after the patients received MMF treatment and serious side effect was not observed.Conclusion:MMF is an effective and safe drug in treatment o...
Keywords:Mycophenolate mofetil  Refractory nephropathy syndrome  Prednisolone  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号